Evidence map›Paper›PMID 37305885›Full record

ArticleClinical case reports2023

Psoriasis-like skin rash triggered by a local infection in a patient with eosinophilic granulomatosis with polyangiitis that was well controlled by mepolizumab treatment.

Naho Yokota, Makoto Kondo, Akinobu Hayashi, Masako Ichishi, Yoshiaki Matsushima, Takehisa Nakanishi, Koji Habe, Keiichi Yamanaka

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Naho YokotaDepartment of Dermatology Graduate School of Medicine, Mie University Tsu Japan.
Makoto KondoDepartment of Dermatology Graduate School of Medicine, Mie University Tsu Japan.ORCID https://orcid.org/0000-0003-1560-6067
Akinobu HayashiDepartment of Pathology Graduate School of Medicine, Mie University Tsu Japan.
Masako IchishiDepartment of Pathology Graduate School of Medicine, Mie University Tsu Japan.
Yoshiaki MatsushimaDepartment of Dermatology Graduate School of Medicine, Mie University Tsu Japan.
Takehisa NakanishiDepartment of Dermatology Graduate School of Medicine, Mie University Tsu Japan.
Koji HabeDepartment of Dermatology Graduate School of Medicine, Mie University Tsu Japan.
Keiichi YamanakaDepartment of Dermatology Graduate School of Medicine, Mie University Tsu Japan.ORCID https://orcid.org/0000-0003-3055-5202
Mie University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical message: A patient with eosinophilic granulomatosis with polyangiitis, who was well-controlled by pharmacotherapy, developed a psoriasis-like rash due to a local infection. It represents the consequence of an immunologic imbalance. Abstract: A 48-year-old woman was diagnosed with eosinophilic granulomatosis with polyangiitis and treated with mepolizumab. While on treatment, she developed a psoriasis-like rash on her lower legs following a local ear infection. The rash promptly disappeared after the ear infection cleared and did not recur. The psoriasis-like rash that appeared was pathologically similar to psoriasis. Excessive production of inflammatory cytokines by the immune system is believed to be involved in the pathogenesis of psoriasis vulgaris. These cytokines are known to induce inflammatory responses and promote epidermal cell proliferation. It is possible that mepolizumab treatment suppressed Th2-type cytokines, while the local ear infection temporarily induced a strong Th1-type immunity. This immunologic imbalance may have led to the development of a psoriasis-like rash.

Indexed as

EGPAimmunostaininglocal infectionmepolizumabpsoriasis vulgaris

Identifiers

PMID37305885
PMCPMC10256866
OpenAlexW4380153567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.